AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34168425 — intervention group
Group type: COMPARATOR
Intervention: Room temperature irrigating solution (20.0±0.1°C)
Number of subjects: 100
Study 36402700 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab, Bortezomib, and Dexamethasone (D-Vd)
Number of subjects: 211
Study 36402700 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib and Dexamethasone (Vd)
Number of subjects: 211
Study 33881605 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment followed by skin surface application of a cosmeceutical containing growth factors (GFs) and Vitamin C
Number of subjects: 132
Study 33881605 — intervention group
Group type: COMPARATOR
Intervention: Laser resurfacing followed by skin surface application of Vitamin C
Number of subjects: 132
Study 32471651 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies that declared funding and adherence to CONSORT
Number of subjects: 303
Study 32471651 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall randomised controlled trials in oral and maxillofacial surgery
Number of subjects: 303
Study 35964661 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery room insertion of etonogestrel contraceptive implant (0-2 hours post-delivery)
Number of subjects: 95
Study 35964661 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion of etonogestrel contraceptive implant (24-48 hours post-delivery)
Number of subjects: 95
Study 35964661 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery room insertion of etonogestrel contraceptive implant
Number of subjects: 95
Study 35964661 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion of etonogestrel contraceptive implant
Number of subjects: 95
Study 35964661 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (delivery room and delayed insertion)
Number of subjects: 95
Study 34726708 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-dose amoxicillin (35-50 mg/kg/d)
Number of subjects: 824
Study 34726708 — intervention group
Group type: COMPARATOR
Intervention: Higher-dose amoxicillin (70-90 mg/kg/d)
Number of subjects: 824
Study 34726708 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day treatment
Number of subjects: 824
Study 34726708 — intervention group
Group type: COMPARATOR
Intervention: 7-day treatment
Number of subjects: 824
Study 34726708 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-dose amoxicillin in severe CAP
Number of subjects: 824
Study 34726708 — intervention group
Group type: COMPARATOR
Intervention: Higher-dose amoxicillin in severe CAP
Number of subjects: 824
Study 34726708 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day treatment in severe CAP
Number of subjects: 824
Study 34726708 — intervention group
Group type: COMPARATOR
Intervention: 7-day treatment in severe CAP
Number of subjects: 824
Study 35381377 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly shipments of five breakfast and lunch meals that mimic school meals
Number of subjects: 100
Study 35381377 — intervention group
Group type: COMPARATOR
Intervention: Weekly newsletter on community resources
Number of subjects: 100
Study 34506689 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula therapy (HFNC)
Number of subjects: 104
Study 34506689 — intervention group
Group type: COMPARATOR
Intervention: Standard low flow nasal oxygen via nasal prongs (NC)
Number of subjects: 104
Study 32932394 — intervention group
Group type: EXPERIMENTAL
Intervention: Scleral lens wear for 4 hours
Number of subjects: 20
Study 35488406 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change interventions
Number of subjects: 5175
Study 35488406 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 5175
Study 32143062 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptually dissimilar condition with similar semantic objects
Number of subjects: 0
Study 32143062 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptually similar condition with similar semantic objects
Number of subjects: 0
Study 32143062 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantically dissimilar condition with similar perceptual objects
Number of subjects: 0
Study 32143062 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantically similar condition with similar perceptual objects
Number of subjects: 0
Study 35895295 — intervention group
Group type: EXPERIMENTAL
Intervention: OVD group (n = 30)
Number of subjects: 60
Study 35895295 — intervention group
Group type: COMPARATOR
Intervention: OVD-free group (n = 30)
Number of subjects: 60
Study 33048561 — intervention group
Group type: EXPERIMENTAL
Intervention: BA + PAD
Number of subjects: 40
Study 33048561 — intervention group
Group type: COMPARATOR
Intervention: PAD-only
Number of subjects: 40
Study 33058123 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived strong family support
Number of subjects: 390
Study 33058123 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 390
Study 33058123 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis of disease for more than 10 years
Number of subjects: 390
Study 33058123 — intervention group
Group type: COMPARATOR
Intervention: General population
Number of subjects: 390
Study 35683982 — intervention group
Group type: EXPERIMENTAL
Intervention: PKU Bite® app
Number of subjects: 81
Study 35683982 — intervention group
Group type: COMPARATOR
Intervention: Written/pictorial material (control)
Number of subjects: 81
Study 34265055 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-sweetened beverage (SB)
Number of subjects: 75
Study 34265055 — intervention group
Group type: EXPERIMENTAL
Intervention: HFCS-sweetened beverage (SB)
Number of subjects: 75
Study 34265055 — intervention group
Group type: COMPARATOR
Intervention: Aspartame-sweetened beverage (SB)
Number of subjects: 75
Study 35089373 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 409306 50 mg
Number of subjects: 20
Study 35089373 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 409306 200 mg
Number of subjects: 20
Study 35089373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34651066 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led, simulator-based training in cardiac physical examination (PE) in addition to standard curricular training
Number of subjects: 89
Study 34651066 — intervention group
Group type: COMPARATOR
Intervention: Standard curricular training only (Control group)
Number of subjects: 89
Study 33785465 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 visits at 2 and 6 weeks after delivery
Number of subjects: 250
Study 33785465 — intervention group
Group type: COMPARATOR
Intervention: Single 6-week postpartum visit (control)
Number of subjects: 250
Study 35145071 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass-Fix
Number of subjects: 575
Study 35145071 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurable Residual Disease (MRD)
Number of subjects: 575
Study 35145071 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass-Fix at 1 year
Number of subjects: 575
Study 35145071 — intervention group
Group type: EXPERIMENTAL
Intervention: MRD at 1 year
Number of subjects: 575
Study 35145071 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass-Fix pre-induction
Number of subjects: 575
Study 35145071 — intervention group
Group type: EXPERIMENTAL
Intervention: SIFE and CR
Number of subjects: 575
Study 33587126 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.014 × 0.014‐in computer‐aided design/computer‐aided manufacturing nitinol retainer (Memotain)
Number of subjects: 132
Study 33587126 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0215‐in 5‐strand stainless steel wire
Number of subjects: 132
Study 33587126 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.016 × 0.022‐in dead‐soft wire
Number of subjects: 132
Study 33587126 — intervention group
Group type: EXPERIMENTAL
Intervention: Connected bonding pads
Number of subjects: 132
Study 32157608 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Education and Support (EE-S)
Number of subjects: 432
Study 32157608 — intervention group
Group type: COMPARATOR
Intervention: Support and Delayed Education (S-DE)
Number of subjects: 432
Study 35643218 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration
Number of subjects: 39
Study 35643218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 34753843 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini implants
Number of subjects: 32
Study 34753843 — intervention group
Group type: EXPERIMENTAL
Intervention: Connecticut intrusion arch
Number of subjects: 32
Study 34753843 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental intrusion arch
Number of subjects: 32
Study 32296118 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic dataset for training instance segmentation neural network
Number of subjects: 0
Study 35977110 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 W pedaling work rate
Number of subjects: 96
Study 35977110 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 W pedaling work rate
Number of subjects: 96
Study 35977110 — intervention group
Group type: COMPARATOR
Intervention: Nonpedaling condition
Number of subjects: 96
Study 33387976 — intervention group
Group type: EXPERIMENTAL
Intervention: Rise Above (RA), a trauma-informed, e-cigarette preventive intervention
Number of subjects: 0
Study 33387976 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35119705 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 80
Study 35119705 — intervention group
Group type: COMPARATOR
Intervention: Liquid nitrogen cryotherapy
Number of subjects: 80
Study 34865105 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesorectal excision with lateral lymph node dissection
Number of subjects: 663
Study 34865105 — intervention group
Group type: COMPARATOR
Intervention: Mesorectal excision alone
Number of subjects: 663
Study 35475592 — intervention group
Group type: EXPERIMENTAL
Intervention: ITC-rich broccoli sprout extract (BSE) (200 µmol ITC per day)
Number of subjects: 30
Study 35475592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33857411 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobaplatin-based induction chemotherapy (lobaplatin 30 mg/m2 on days 1 and 22, fluorouracil 800 mg/m2 on days 1-5 and 22-26 for two cycles) followed by concurrent lobaplatin-based chemoradiotherapy.
Number of subjects: 502
Study 33857411 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin-based induction chemotherapy (cisplatin 100 mg/m2 on days 1 and 22, fluorouracil 800 mg/m2 on days 1-5 and 22-26 for two cycles) followed by concurrent cisplatin-based chemoradiotherapy.
Number of subjects: 502
Study 33857411 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobaplatin-based induction chemotherapy (lobaplatin 30 mg/m2) in per-protocol population.
Number of subjects: 502
Study 33857411 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin-based induction chemotherapy (cisplatin 100 mg/m2) in per-protocol population.
Number of subjects: 502
Study 33857411 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events in lobaplatin group.
Number of subjects: 502
Study 33857411 — intervention group
Group type: COMPARATOR
Intervention: Adverse events in cisplatin group.
Number of subjects: 502
Study 34320702 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 128
Study 34320702 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia combined with Epidural Anesthesia (GAEA)
Number of subjects: 128
Study 32928709 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 300 mg Q4W
Number of subjects: 803
Study 32928709 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg Q2W
Number of subjects: 803
Study 32928709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 803
Study 35834764 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Personalized Feedback Intervention (PFI)
Number of subjects: 269
Study 35834764 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Personalized Feedback Intervention (PFI)
Number of subjects: 269
Study 32519569 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler ultrasound group
Number of subjects: 230
Study 32519569 — intervention group
Group type: COMPARATOR
Intervention: Clinical examination group
Number of subjects: 230
Study 36221329 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal activated carbon smokeless moxibustion
Number of subjects: 88
Study 36221329 — intervention group
Group type: COMPARATOR
Intervention: Traditional moxibustion
Number of subjects: 88
Study 32818573 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract
Number of subjects: 80
Study 32818573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32877471 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing students in cohort A (+PT)
Number of subjects: 119
Study 32877471 — intervention group
Group type: COMPARATOR
Intervention: Nursing students in cohort B (−PT)
Number of subjects: 119
Study 36385038 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIA with low basal infusion
Number of subjects: 160
Study 36385038 — intervention group
Group type: COMPARATOR
Intervention: PCIA with no basal infusion
Number of subjects: 160
Study 32088665 — intervention group
Group type: EXPERIMENTAL
Intervention: PNMES
Number of subjects: 124
Study 32088665 — intervention group
Group type: COMPARATOR
Intervention: Sham PNMES
Number of subjects: 124
Study 32521133 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus mechanical thrombectomy (thrombectomy group)
Number of subjects: 300
Study 32521133 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (control group)
Number of subjects: 300
Study 33759742 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy for social anxiety disorder in adolescents (CT‐SAD‐A)
Number of subjects: 12
Study 35638207 — intervention group
Group type: EXPERIMENTAL
Intervention: BoneMaster coating (PBM group)
Number of subjects: 53
Study 35638207 — intervention group
Group type: COMPARATOR
Intervention: Only porous titanium plasma-sprayed coating (P group)
Number of subjects: 53
Study 34610572 — intervention group
Group type: EXPERIMENTAL
Intervention: ZIKV-Ig (50.0 mL intravenous dose)
Number of subjects: 30
Study 34610572 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 30
Study 34370331 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation (GPR)
Number of subjects: 80
Study 34370331 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - no treatment
Number of subjects: 80
Study 32659162 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings
Number of subjects: 60
Study 32659162 — intervention group
Group type: COMPARATOR
Intervention: Control (no compression stockings)
Number of subjects: 60
Study 36168148 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole oral film (ROF) 50 mg
Number of subjects: 41
Study 36168148 — intervention group
Group type: COMPARATOR
Intervention: Riluzole tablets 50 mg
Number of subjects: 41
Study 36168148 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole oral film (ROF) 50 mg with food
Number of subjects: 41
Study 34688917 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (PPAR-γ agonist) adjunctive to cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 34688917 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 34628066 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy using a 670-nm light-emitting eye patch, applied for 90 seconds twice daily for 4 months.
Number of subjects: 135
Study 34628066 — intervention group
Group type: COMPARATOR
Intervention: Placebo using an identical device emitting broad-spectrum white light at low power, applied for 90 seconds twice daily for 4 months.
Number of subjects: 135
Study 33394894 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear Programming (LP)
Number of subjects: 43
Study 33394894 — intervention group
Group type: EXPERIMENTAL
Intervention: Undulating Programming (UP)
Number of subjects: 43
Study 33394894 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse Programming (RP)
Number of subjects: 43
Study 33394894 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant Programming (CP)
Number of subjects: 43
Study 33095939 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate fruit extract (PFE) 1000 mg once daily for twelve months
Number of subjects: 30
Study 33095939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32050648 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (10 sets of 6 s all‐out cycling interspersed with 9 s of rest)
Number of subjects: 43
Study 32050648 — intervention group
Group type: EXPERIMENTAL
Intervention: MICT (30 min cycling at 50%‐60% of peak oxygen consumption, V̇O2peak)
Number of subjects: 43
Study 32050648 — intervention group
Group type: COMPARATOR
Intervention: No-exercise controls (CON)
Number of subjects: 43
Study 32050648 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 43
Study 32050648 — intervention group
Group type: EXPERIMENTAL
Intervention: MICT
Number of subjects: 43
Study 32050648 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT and MICT
Number of subjects: 43
Study 33921792 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit consumption
Number of subjects: 36496
Study 33921792 — intervention group
Group type: EXPERIMENTAL
Intervention: Light levels of physical activity
Number of subjects: 36496
Study 33921792 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk consumption
Number of subjects: 36496
Study 35951068 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymosin α1 plus blood purification (BP) therapy
Number of subjects: 86
Study 35951068 — intervention group
Group type: COMPARATOR
Intervention: Blood purification (BP) treatment only
Number of subjects: 86
Study 34629245 — intervention group
Group type: EXPERIMENTAL
Intervention: 2800 IU of vitamin D3 per day
Number of subjects: 200
Study 34629245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 36415299 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management education program based on 5A model in five sessions during two months
Number of subjects: 54
Study 32871870 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI (Omeprazole; 40 mg twice daily)
Number of subjects: 12
Study 36141796 — intervention group
Group type: EXPERIMENTAL
Intervention: RDIR (computerized intensive remediation strategy)
Number of subjects: 32
Study 36141796 — intervention group
Group type: EXPERIMENTAL
Intervention: RDOR (ordinary remediation strategy)
Number of subjects: 32
Study 36141796 — intervention group
Group type: COMPARATOR
Intervention: Control group (Normal readers)
Number of subjects: 32
Study 32303499 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly ranibizumab 0.3 mg every 4 weeks
Number of subjects: 150
Study 32303499 — intervention group
Group type: EXPERIMENTAL
Intervention: TREX (treat-and-extend ranibizumab without laser)
Number of subjects: 150
Study 32303499 — intervention group
Group type: EXPERIMENTAL
Intervention: GILA (treat-and-extend ranibizumab with laser)
Number of subjects: 150
Study 32303499 — intervention group
Group type: EXPERIMENTAL
Intervention: All cohorts in the third year
Number of subjects: 150
Study 32372585 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored counselling by a preventive nurse (telephone then mail)
Number of subjects: 304
Study 32372585 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tailored counselling)
Number of subjects: 304
Study 32372585 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse's interventions (post-intervention analysis)
Number of subjects: 304
Study 32372585 — intervention group
Group type: EXPERIMENTAL
Intervention: Sociological analysis of families
Number of subjects: 304
Study 35869988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine pouches (NPs) with 1.5 mg nicotine
Number of subjects: 0
Study 35869988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine pouches (NPs) with 2 mg nicotine
Number of subjects: 0
Study 35869988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine pouches (NPs) with 3.5 mg nicotine
Number of subjects: 0
Study 35869988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine pouches (NPs) with 8 mg nicotine
Number of subjects: 0
Study 35869988 — intervention group
Group type: COMPARATOR
Intervention: Own brand cigarettes (OBC)
Number of subjects: 0
Study 35869988 — intervention group
Group type: COMPARATOR
Intervention: Moist smokeless tobacco (OBMST)
Number of subjects: 0
Study 35869988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine pouches (NPs)
Number of subjects: 0
Study 33006445 — intervention group
Group type: EXPERIMENTAL
Intervention: IV peramivir
Number of subjects: 179
Study 33006445 — intervention group
Group type: COMPARATOR
Intervention: Oral oseltamivir
Number of subjects: 179
Study 34969409 — intervention group
Group type: EXPERIMENTAL
Intervention: Humanized nursing care
Number of subjects: 50
Study 34969409 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 50
Study 33248605 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 at 5,520 IU/kg (DD)
Number of subjects: 390
Study 33248605 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 at 2,760 IU/kg plus 25OHD at 2,760 IU (25D)
Number of subjects: 390
Study 33248605 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D3 at 2,760 IU/kg (D)
Number of subjects: 390
Study 33248605 — intervention group
Group type: EXPERIMENTAL
Intervention: 25OHD
Number of subjects: 390
Study 36184248 — intervention group
Group type: EXPERIMENTAL
Intervention: NRS-2002 scores by researchers
Number of subjects: 0
Study 36184248 — intervention group
Group type: COMPARATOR
Intervention: NRS-2002 scores by department nurses
Number of subjects: 0
Study 33719093 — intervention group
Group type: EXPERIMENTAL
Intervention: NeuroN-QI intervention (four 2-hour skin-to-skin contact sessions/week with 15-minute auditory stimulation, followed by a 1-hour quiet period)
Number of subjects: 24
Study 33719093 — intervention group
Group type: COMPARATOR
Intervention: Standard care (four skin-to-skin contacts per week)
Number of subjects: 24
Study 32386940 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson relaxation + routine care
Number of subjects: 93
Study 32386940 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation + routine care
Number of subjects: 93
Study 32386940 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 93